Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.14 (-8.64%)
Close on Nov 16, 2026Market cap $55.39MP/E –Yield –
Tenax Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Tenax Therapeutics's total assets was $121.66M at Jun 30, 2026. For fiscal 2025 it was $104.23M, up 7.8% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $104.23M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.23M | +7.8% |
| FY2024 | Dec 31, 2024 | $96.69M | +727.4% |
| FY2023 | Dec 31, 2023 | $11.69M | +243.2% |
| FY2022 | Dec 31, 2022 | $3.40M | -43.2% |
| FY2021 | Dec 31, 2021 | $5.99M | -12.8% |
| FY2020 | Dec 31, 2020 | $6.87M | +7.9% |
| FY2019 | Dec 31, 2019 | $6.37M | -52.3% |
| FY2018 | Dec 31, 2018 | $13.34M | +34.8% |
| FY2017 | Dec 31, 2017 | $9.89M | -88.1% |
| FY2015 | Apr 30, 2015 | $82.91M | -11.3% |
| FY2014 | Apr 30, 2014 | $93.43M | +2837.4% |
| FY2013 | Apr 30, 2013 | $3.18M | -23.2% |
| FY2012 | Apr 30, 2012 | $4.14M | +41.7% |
| FY2011 | Apr 30, 2011 | $2.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $121.66M | +14.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $123.18M | +9.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $104.23M | +7.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $102.81M | +3.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $105.86M | +897.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $112.06M | +674.9% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $96.69M | +727.4% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $99.78M | +739.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $10.62M | -24.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $14.46M | -5.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $11.69M | +243.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $11.89M | +150.9% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $14.05M | +68.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $15.27M | +308.6% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $3.40M | -43.2% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $4.74M | -46.8% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $8.36M | +189.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $3.74M | -18.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $5.99M | -12.8% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $8.91M | -0.9% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $2.89M | -46.1% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $4.56M | -23.4% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $6.87M | +7.9% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $9.00M | +15.7% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $5.35M | -44.6% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $5.95M | -48.0% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $6.37M | -52.3% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $7.77M | +42.5% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $9.66M | +37.6% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $11.46M | +37.8% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $13.34M | +34.8% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $5.45M | -50.4% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $7.03M | -47.8% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $8.31M | -56.6% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $9.89M | -88.1% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $11.00M | -87.2% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $13.45M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $19.15M | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | $82.91M | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | $86.19M | – |
See a number that looks wrong?